%5BAngiogenesis inhibitors for the systemic treatment of met…
%5BAngiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma%3A sunitinib%2C sorafenib%2C bevacizumab and temsirolimus%5D
Article, Chapter
Authors:
P.H.M. de Mulder
Publication:
Volume:152,
Page(s):371
Published:
2008
We were unable to find direct full text links for this item.